Studies have found [22] that the percentage of CD3+, CD4+, CD4+/CD8+, and NK cells in peripheral blood of NSCLC patients with stage IV was negatively correlated with the number of circulating tumor cells. This evidence concerns the gene CD4 and neoplasm.